Cigna Corp (CGN.BE)
| Previous close | 310.50 |
| Open | 310.90 |
| Bid | 308.05 x 0 |
| Ask | 313.10 x 0 |
| Day's range | 310.45 - 311.15 |
| 52-week range | 225.70 - 340.15 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
The Cigna Group Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, President and CEO of Cigna Healthcare, will present at Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami, FL.
- PR Newswire
The Cigna Group Ranks No. 7 in Fair360 Top 50 Companies
Global health company The Cigna Group (NYSE: CI) announced today that it is No. 7 on Fair360's 2024 Top 50 Companies – seven spots higher than last year's ranking – demonstrating The Cigna Group's long-standing and deep commitment to equal opportunity for all. Fair360 announced its 2024 Top 50 honorees this week, recognizing The Cigna Group for its workplace practices, philanthropy, leadership accountability, supplier fairness, human capital, and talent programs.
- PR Newswire
The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook
Global health company The Cigna Group (NYSE: CI) today reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses.
